
7MM triple-negative breast cancer market eyes 4.7% CAGR growth until 2034
The sector’s expansion is attributed to rising incidence rates. The triple-negative breast cancer (TNBC) market across the seven major markets (7MM) is expected to expand at a compound annual growth rate of 4.7% through 2034, according to a DelveInsight …